Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow CellsBone Marrow PurgingTransplantation, HomologousWhole-Body IrradiationCombined Modality TherapyGraft vs Host DiseaseCyclophosphamideLymphoma, Non-HodgkinCarmustineBone and BonesHematopoietic Stem Cell TransplantationLeukemiaTransplantation ConditioningMelphalanBusulfanRemission InductionLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsHodgkin DiseaseAnemia, AplasticRecurrenceEtoposideGraft SurvivalBone Marrow DiseasesColony-Forming Units AssayPrecursor Cell Lymphoblastic Leukemia-LymphomaTreatment OutcomeTissue DonorsHematopoiesisCytarabineLeukemia, MyeloidActuarial AnalysisTransplantation ChimeraSurvival AnalysisHistocompatibility TestingTime FactorsHistocompatibilityAcute DiseaseTransplantation, IsogeneicVincristineImmunosuppressionPodophyllotoxinImmunosuppressive AgentsLymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationDisease-Free SurvivalBone RemodelingHematologic NeoplasmsSalvage TherapySurvival RateDrug EvaluationFollow-Up StudiesKidney TransplantationLeukocyte CountCyclosporineThiotepaRetrospective StudiesMice, Inbred C57BLBone Marrow NeoplasmsMyelodysplastic SyndromesCytomegalovirus InfectionsRadiation ChimeraLiver TransplantationGraft RejectionStem Cell TransplantationHepatic Veno-Occlusive DiseaseHematologic DiseasesGranulocyte Colony-Stimulating FactorT-LymphocytesMultiple MyelomaGranulocytesPrognosisAntibodies, MonoclonalNeutropeniaProspective StudiesLymphocyte DepletionGranulocyte-Macrophage Colony-Stimulating FactorGraft vs Host ReactionBone DensityPrednisonePlatelet CountHLA AntigensBlood Cell CountLymphatic IrradiationCell SeparationMitoxantroneAgranulocytosisOpportunistic InfectionsNeuroblastomaCell DifferentiationImmunocompromised HostMethotrexateLeukocyte TransfusionPolymerase Chain ReactionDoxorubicin